Preclinical and clinical development of neoantigen vaccines

Por Li, L, Goedegebuure, S P, Gillanders, W E
Publicado no Ann Oncol (2017)

PTP1B expression is an independent positive prognostic factor in human breast cancer

Por Soysal, S., Obermann, E. C., Gao, F., Oertli, D., Gillanders, W. E., Viehl, C. T., Muenst, S.
Publicado em 2012

Prostate-Specific Ets (PSE) factor: a novel marker for detection of metastatic breast cancer in axillary lymph nodes

Por Mitas, M, Mikhitarian, K, Hoover, L, Lockett, M A, Kelley, L, Hill, A, Gillanders, W E, Cole, D J
Publicado em 2002

EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2(+), basal-like, and HER2 intrinsic subtypes of breast cancer

Por Soysal, S D, Muenst, S, Barbie, T, Fleming, T, Gao, F, Spizzo, G, Oertli, D, Viehl, C T, Obermann, E C, Gillanders, W E
Publicado em 2013

Myeloid-derived suppressor cells: general characteristics and relevance to clinical management of pancreatic cancer

Por Goedegebuure, P., Mitchem, J.B., Porembka, M.R., Tan, M.C.B., Belt, B.A., Wang-Gillam, A., Gillanders, W.E., Hawkins, W.G., Linehan, D.C.
Publicado em 2011

Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer

Por Muenst, S., Schaerli, A. R., Gao, F., Däster, S., Trella, E., Droeser, R. A., Muraro, M. G., Zajac, P., Zanetti, R., Gillanders, W. E., Weber, W. P., Soysal, S. D.
Publicado em 2014

Identification and translational validation of novel mammaglobin-A CD8 T cell epitopes

Por Soysal, S. D., Muenst, S., Kan-Mitchell, J., Huarte, E., Zhang, X., Wilkinson-Ryan, I., Fleming, T., Tiriveedhi, V., Mohanakumar, T., Li, L., Herndon, J., Oertli, D., Goedegebuure, S. P., Gillanders, W. E.
Publicado no Breast Cancer Res Treat (2014)